Therapeutic options here are based on EMA drug approvals with deviating approval details clearly marked. Drugs availability may vary in your country.

Experts
The FGFR-Portal is scientifically accompanied by

Prof. Dr. med. Arndt Hartmann - Professor of Pathology Director of the Institute of Pathology University Hospital Erlangen

Prof. Dr. med. Arndt Hartmann

Professor of Pathology
Director of the Institute of Pathology
University Hospital Erlangen


Dr. med. Veronika Bahlinger - Resident and Research Training in Uropathology, Institute of Pathology University Hospital Erlangen

Dr. med. Veronika Bahlinger

Resident and Research Training in Uropathology, Institute of Pathology
University Hospital Erlangen


Prof. Dr. med. Albrecht Stenzinger - Professor of Molecular Tumor Pathology, Deputy Director of the Institute of Pathology (IPH), Head of the IPH Center for Molecular Pathology

Prof. Dr. med. Albrecht Stenzinger

Professor of Molecular Tumor Pathology, Deputy Director of the Institute of Pathology (IPH), Head of the IPH Center for Molecular Pathology


PD Dr. rer. nat. Daniel N. Kazdal - Head of Technology and Assay Development of the Center for Molecular Pathology of the Institute of Pathology Heidelberg

PD Dr. rer. nat. Daniel N. Kazdal

Head of Technology and Assay Development of the Center for Molecular Pathology of the Institute of Pathology Heidelberg


Prof. Dr. med. Arndt Vogel - Senior Physician, Head of the Center for Personalized Medicine, Head of the Visceral Oncology Center

Prof. Dr. med. Arndt Vogel

Senior Physician, Head of the Center for Personalized Medicine, Head of the Visceral Oncology Center


Prof. Dr. med. Johannes Breyer - Specialist in Urology Medical Tumor Therapy Senior Physician Clinic of Urology at Caritas Hospital St. Josef Department of the University of Regensburg

Prof. Dr. med. Johannes Breyer

Specialist in Urology
Medical Tumor Therapy
Senior Physician Clinic of Urology
at Caritas Hospital St. Josef
Department of the University of Regensburg